Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Shimadzu Corporation    7701   JP3357200009

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Shimadzu Corporation : New Aggregates Sizer Aggregation Analysis System for Biopharmaceuticals Enables Real-time Quantitative Evaluation of 100 nm to 10 m SVP (sub-visible particle) Aggregates

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/11/2013 | 09:19am CEST
Press Release
07/11/13
New Aggregates Sizer Aggregation Analysis System for Biopharmaceuticals Enables Real-time Quantitative Evaluation of 100 nm to 10 µm SVP (sub-visible particle) Aggregates

Shimadzu Corporation released the Aggregates Sizer Aggregation Analysis System for Biopharmaceuticals on July 10.

The Aggregates Sizer Aggregation Analysis System for Biopharmaceuticals offers quantitative, high-speed evaluation of 100 nm to 10 µm SVP (sub-visible particle) aggregates that may be present in biopharmaceuticals. Capable of evaluating the concentration (µg/mL) of aggregates that can cause shock symptom or other side effects, it is ideally suited for quality control and for improving the efficiency of biopharmaceutical development.

Background to Development

Biopharmaceuticals are essential to modern medicine, accounting for four of the top five products in 2012 drug sales, and the market is expected to reach $ 210 billion by 2015*. However, the generation of SVP aggregates in the sub-visible range due to mechanical stimulation or temperature changes, and the severe side effects that this induces, such as anaphylaxis (allergic systemic reactions), are concerning. Until now, no effective SVP aggregate analysis technique has been established. Shimadzu's new system significantly reduces costs and development times by allowing samples to be evaluated for aggregation at the early stages of biopharmaceutical development. In addition, it allows aggregation-prone proteins to be screened and eliminated in advance.

* Source: Cedium strategic data site

Features of the New Product 1. Quantitatively evaluates SVP range aggregate concentrations

The Aggregates Sizer measures aggregates of a wide range of particles sizes, from 7 nm to 800 µm, as part of a particle size distribution (displayed with particle quantities totaling 100 %). Furthermore, it enables quantitative evaluation (in terms of µg/mL) of aggregate concentrations in the SVP (sub-visible particle) range, from 100 nm to 10 µm.

2. Measures aggregates with sensitivity 10 times higher than previous particle size analyzers

The Aggregates Sizer is over ten times more sensitive than Shimadzu's previous SALD series particle size analyzers. This means that even micro sample quantities can be measured accurately using disposable cells for 0.4 mL sample quantities.

3. Quantitatively evaluates aggregation processes at intervals as short as one second

Changes (sizes and quantities) in aggregates can be confirmed quantitatively as a concentration (unit: µg/mL) at intervals as short as one second. This allows observing the status at various intermediate stages in order to evaluate rates of change. In addition, a batch cell (5 mL sample capacity) enables observation of aggregation processes as samples are mechanically stimulated.

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SHIMADZU CORPORATION
01:51p SHIMADZU : China Mass Spectrometry Center Received an iF DESIGN AWARD 2017
03/29 SHIMADZU CORPORATION : ex-dividend day for final dividend
03/27 SHIMADZU : New Analysis Kit Enables Efficient Measurement of 1 mm or Smaller Con..
03/24 SHIMADZU : New Cannabis Analyser for Potency Provides Effortless Determination o..
03/24 SHIMADZU : to boost investment in early detection of cancer
03/23 SHIMADZU : Patent Issued for Radiographic Apparatus (USPTO 9592015)
03/23 SHIMADZU : Patent Issued for Method and System for Mass Spectrometry Data Analys..
03/23 SHIMADZU : New Triple Quadrupole GCMS Achieves World's Highest Sensitivity Down ..
03/17 METTLER TOLEDO INTERNATIONAL : Global TOC Analyzers Market- Hach, Mettler Toledo..
03/16 SHIMADZU : Patent Issued for Ultrasonic Fatigue Testing Machine and Ultrasonic F..
More news
Sector news : Testing & Measuring Equipment
03/03 Exclusive - Japan's Toshiba prepares $2 billion sale of Landis+Gyr - sources
03/03 EXCLUSIVE : Japan's Toshiba prepares $2 billion sale of Landis+Gyr - sources
02/22 Weir hurt by weak oil prices while peer Petrofac sees order uptick
02/08DJINGERSOLL RAND : Files 8K - Regulation FD
02/02DJPARKER HANNIFIN : Boosts Earnings Guidance as Profit Rises
More sector news : Testing & Measuring Equipment
Advertisement
Financials ( JPY)
Sales 2017 339 662 M
EBIT 2017 -
Net income 2017 26 271 M
Finance 2017 41 250 M
Yield 2017 1,11%
P/E ratio 2017 21,61
P/E ratio 2018 19,21
EV / Sales 2017 1,45x
EV / Sales 2018 1,35x
Capitalization 532 334 M
More Financials
Chart SHIMADZU CORPORATION
Duration : Period :
Shimadzu Corporation Technical Analysis Chart | 7701 | JP3357200009 | 4-Traders
Full-screen chart
Technical analysis trends SHIMADZU CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 2 246  JPY
Spread / Average Target 25%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Teruhisa Ueda Executive President, CEO & Representative Director
Akira Nakamoto Executive Chairman
Yoshiaki Mase Head-Information Systems & Manufacturing
Satoru Suzuki Director & Head-Technology Research
Hiroshi Fujino Director, Head-Investor & Public Relations
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SHIMADZU CORPORATION-3.85%4 786
SMC CORP20.10%20 285
METTLER-TOLEDO INTERNA..14.23%12 386
COGNEX CORPORATION29.74%7 152
KEYSIGHT TECHNOLOGIES ..-0.55%6 655
MKS INSTRUMENTS, INC.14.98%3 679
More Results